Shares of Datavault AI (DVLT) surged 8.8% to $0.54 after the company announced a non-binding term sheet for a potential $2 billion structured financing — a staggering figure for a company whose entire market capitalization sits around $450 million. The deal sounds transformative on paper. The fine print tells a more complicated story.
The $2 Billion Is Not Cash — It's an Asset Swap
The proposed transaction would involve issuing shares at $1.55 to $2.00 per share in exchange for preferred units in an investment vehicle holding a portfolio of fixed-income securities valued at roughly $2.0 billion.
The transaction is structured as an asset-backed arrangement rather than a conventional cash placement. In plain English: Datavault isn't receiving a $2 billion wire transfer. It's trading newly created stock for someone else's bond portfolio. That distinction matters enormously for what shareholders actually get.
Dilution Could Be Massive — and So Could the Loss of Control
DVLT currently has 855.56 million shares outstanding. At the proposed $1.55–$2.00 per share, issuing $2 billion worth of stock could add roughly 1 to 1.3 billion new shares, nearly doubling the count. The counterparty would gain the right to nominate one board director per tranche and, upon the final tranche, would gain majority board control.
The deal still requires definitive agreements, shareholder approval, antitrust clearance, and a CFIUS review.
Datavault Must Pay $25 Million Per Tranche — Starting in Days
The agreement requires Datavault AI to provide $25 million in administrative and structuring costs for each tranche, with the first payment due by June 4, 2026. That's a steep upfront tab for a company that holds just $2.21 million in cash and burned $27 million in free cash flow over the last twelve months. The company says it will fund the payment from bitcoin and receivables sales — an unusual and unproven financing path.
Revenue Is Growing Fast, But From a Tiny Base
Q1 2026 revenue was $3.4 million, up 443% year over year.
Despite revenue growth exceeding 1,200% over the trailing twelve months, the company remains unprofitable with a loss per share of -$0.43.
Management reaffirmed a full-year 2026 revenue target of at least $200 million — a target that would require an extraordinary ramp from the current quarterly run rate. The gap between ambition and execution here is vast, and this deal, still non-binding and loaded with conditions, does nothing to close it yet.